Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Merson Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company focuses on several therapeutic areas, including gastroenterology, neurology, and cardiovascular health, with a significant portfolio of generic medications. Its manufacturing facilities are compliant with Chinese Good Manufacturing Practice (GMP) standards, enabling the production of tablets, capsules, and granules for the domestic market. Beijing Merson is known for producing widely used treatments such as famotidine for gastric conditions and sulpiride for psychiatric indications. The company operates as a key player in the regional pharmaceutical supply chain, providing essential medicines to hospitals and pharmacies across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Merson Pharmaceutical.